Levels of soluble ICAM-1 and soluble IL-2R in the serum and aqueous humor of uveitis patients

Current Eye Research

Volumn 20, Issue 4, 2000, Pages 287-292

  Martin, Carmen Marcos ^a,c   Lacomba, Manuel Santos ^a   Molina, Carlos Ignacio Serrano ^b   Chamond, Rafael Ramirez ^a   Galera, Jose Maria Gallardo ^a   Estevez, Eduardo Collantes ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b HOSPITAL SAN AGUSTÍN   (Spain)

^c NONE   (Spain)

Author keywords

Activation markers; Aqueous humor; Soluble ICAM 1; Soluble IL 2R; Uveitis

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR;

ADULT; AGED; AQUEOUS HUMOR; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; UVEITIS;

EID: 0033946799     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/0271-3683(200004)2041-5FT287     Document Type: Article

References (30)

1. Deschênes J, Char DH ,Kaleta S. Activated T lymphocytes in uveitis. Br J Ophthalmol. 1988;72:83-87.
2. Kauhn LS, Schlaegel TF, Weber JC, Biegel A. Serum immunoglobulins and uveitis. Arch Ophthalmol. 1983; 101:458-459.
3. Snyder DS, Tessler HH, Yokoyoma MM. Immunologic studies on Vogt-Koyanagi-Harada syndrome and pars planitis. In: Immunology and Immunopathology of the Eye. New York: Ed. Silverstein AM and O'Connor GR. Masson; 1979:68-75.
4. Smith KA. Interleukin-2: inception, impact and implications. Science. 1988;240:1169-1176.
5. Rubin LA, Kurman CC, Fritz ME, Biddison WE, Boutin B, Yarchoan R, Nelson DL. Soluble IL-2 receptors are released from activated human lymphoid cells in vitro. J Immunol. 1985;135:3172-3177.
6. Wagner DK, Kiwanuka J, Edwards BK, Rubin LA, Nelson DL, Magrath IT. Serum interleukin 2 receptor levels in patients with undifferentiated and lymphoblastic lymphomas. Correlation with survival. J Clin Oncol. 1987; 5:1262.
7. Symons JA, Wood NC, Di Giovine FS, Duff GW. Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition. J Immunol. 1988;141:2612.
8. Dittmer R, Harfmann P, Tenschert W, Arndt R, Busch B. Monitoring of renal transplant patients with interleukin-2 and interleukin-2 receptor enzyme immunoassay and interleukin-2 receptor immunocytology. Transplant Proc. 1990;22:2284.
9. Louis E, Belaiche J, Van Kemseke C, Schaaf N, Mahieu P. Soluble interleukin-2 receptor in Crohn's disease. Assessment of disease activity and prediction of relapse. Digest Dis Sci. 1995;40(8):1750-1756.
10. Balzano A, Bove A, Leonardi E, Bevilacqua N, Grande G, Ascierto PA, Castello G. The soluble interleukin-2 receptor as an indicator of clinical evolution in patients with ulcerative colitis. Europ J Gastroenterol Hepatol. 1997;9:173-177.
11. Arocker-Mettinger E, Asenbauer T, Ulbrich S, Grabner G. Serum Interleukin-2 receptor levels in uveitis. Curr Eye Res. 1990;9(Suppl.):25-29.
12. BenEzra D, Maftzir G, Kalichman I, Barak V. Serum levels of Interleukin-2 receptor in ocular Behçet's disease. Am J Ophthalmol. 1993;115:26-30.
13. Scheinberg MA, Ikejiri M, Silva MH, Mota IM. Interleukin-2 receptor membrane in bound and soluble form in the aqueous humor and peripheral blood of patients with acute untreated uveitis. J Rheumatol. 1992;19: 1362-1363.
14. Alpsoy E, Cayirli C, Er H, Yilmaz E. The levels of plasma interleukin-2 and soluble interleukin-2R in Behçet's disease: a marker of disease activity. J Dermatol. 1998;25(8):513-6
15. Dustin ML, Springer TA. T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature. 1989;341:619-623.
16. Seth R, Raymond FD, Makgoba MW. Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet. 1991;338:83-84.
17. Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD. A form of circulating ICAM-1 (cICAM-1) in human serum. J Immunol. 1991;147:3788-3793.
18. Tsukada N, Matsuda M, Miyagi K, Yanagisawa N. Increased levels of intercellular adhesion molecule-1 (ICAM-1) and tumor necrosis factor receptor in the cerebrospinal fluid of patients with multiple sclerosis. Neurol. 1993;43(12):2679-82.
19. De Bellis A, Bizzarro A, Gattoni A. Behavior of soluble intercellular adhesion molecule-1 and endothelial-leukocyte adhesion molecule-1 concentrations in patients with Graves' disease with or without ophthalmopathy and in patients with Toxic Adenoma. J Clin Endocrinol and Metabolism. 1995;80:2118-2121.
20. Webster L, Stanbury RM, Chignell AH, Limb GA. Vitreous intercellular adhesion molecule 1 in uveitis complicated by retinal detachment. Br J Ophthalmol. 1988; 82(4):438-443.
21. Arocker-Mettinger E, Steurer-Georgiew L.,Steurer M, Huber-Spitzy V, Hoelzl E, Grabner G, Kuchar A. Circulating ICAM-1 levels in serum of uveitis patients. Curr Eye Res. 1992;11:161-166.
22. Zaman AG, Edelsten C, Stanford MR, Graham EM, Ellis BA, Kireskeneli H, D'Cruz DP, Hugnes GR, Dumonde DC, Wallace GR. Soluble intercellular adhesion molecule-1 as a marker of disease relapse in idiopathic uveoretinitis. Clin Exp Immunol. 1994;95(1):60-65.
23. Verity DH, Wallace GR, Seed PT, Kanawati CA, Ayesh I, Holland-Gladwish J, Stanford MR Soluble adhesion molecules in Behçet's disease. Ocul Immunol Inflamm. 1988;6(2):81-92.
24. Bloch-Michel E, Nussenblatt RB. International uveitis study group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol. 1987; 103:234-235.
25. Nussenblat RB, Palestine AG, Chan CC. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmol. 1985;92:467.
26. Hogan MH, Kimura SJ, Thygeson P. Signs and symptoms of uveitis: 1. Anterior uveitis. Am J Ophthalmol. 1959;47:155.
27. Woods AC. Endogenous inflammations of the uveal tract. Baltimore: Ed. Williams & Wilkins; 1961:45.
28. Guex-Crosier Y, Raber J, Chan CC, Kriete MS, Benichou J, Pilson RS, Kerwin JA, Waldmann TA, Hakimi J, Roberge FG. Humanized antibodies against the α-chain of the IL-2 receptor and against the β-chain shared by the IL-2 and IL-15 receptors in a monkey uveitis model of autoinmune diseases. J Immunol. 1997;158: 452-458.
29. Rosenbaum JT, Boney RS. Efficacy of antibodies to adhesion molecules, CD11a or CD18, in rabbit models of uveitis. Curr Eye Res. 1993;12(9):827-831.
30. Whitcup SM, Hikita N, Shirao M, Miyasaka M, Tamatani T, Mochizuki M, Nussenbaltt RB, Chan CC. Monoclonal antibodies against CD54 (ICAM-1) and CD11a (LFA-1) prevent and inhibit endotoxin induced uveitis. Exp Eye Res 1995;60(6):597-601.